TLX News: Telix to Present at Jefferies Healthcare Conference - 7th Jun 2022, 9:00pm

[annb0t]

MELBOURNE, Australia and INDIANAPOLIS, June 7, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) a biopharmaceutical company focused on the development and commercialisation of diagnostic and therapeutic products using Molecularly Targeted Radiation (MTR) advises that Dr Christian Behrenbruch, Group CEO and Managing Director will be presenting at the Jefferies Healthcare Conference in New York. (PRNewsfoto/Telix Pharmaceuticals Limited)

The presentation wil...

>>> Read more: Telix to Present at Jefferies Healthcare Conference